Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients

Korean Journal of Internal Medicine

Volumn 30, Issue 2, 2015, Pages 198-204

  Lee, Wan Soo ^a   Kang, Dae Woong ^a   Back, Jong Hun ^a   Kim, Hyun Lee ^a   Chung, Jong Hoon ^a   Shin, Byung Chul ^a  

^a Chosun University   (South Korea)

Author keywords

Chronic; Cut off value; Infection; Kidney failure; Procalcitonin

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; AUTACOID; BIOLOGICAL MARKER; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE COUNT; MALE; PERITONEAL DIALYSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; AREA UNDER THE CURVE; BACTERIAL INFECTIONS; BLOOD; CASE CONTROL STUDY; COMPLICATION; KIDNEY FAILURE, CHRONIC; MICROBIOLOGY; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; UPREGULATION;

ADULT; AGED; AREA UNDER CURVE; BACTERIAL INFECTIONS; BIOMARKERS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; UP-REGULATION;

EID: 84924367128     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.30.2.198     Document Type: Article

References (20)

1. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-1525.
2. Lu XL, Xiao ZH, Yang MY, Zhu YM. Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 2013;28:122-129.
3. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009;37:497-507.
4. Hur M, Moon HW, Yun YM, Kim KH, Kim HS, Lee KM. Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis. Korean J Lab Med 2009;29:529-535.
5. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 2005;351:17-29.
6. Pfafflin A, Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009;393:1473-1480.
7. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001;38(Pt 5):483-493.
8. Boucher BA. Procalcitonin: clinical tool or laboratory curiosity? Crit Care Med 2000;28:1224-1225.
9. Kuse ER, Langefeld I, Jaeger K, Kulpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 2000;28:555-559.
10. Herget-Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001;16:975-979.
11. Lavin-Gomez BA, Palomar-Fontanet R, Gago-Fraile M, et al. Inflammation markers, chronic kidney disease, and renal replacement therapy. Adv Perit Dial 2011;27:33-37.
12. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
13. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000;28:68-73.
14. Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med 2009;24:337-342.
15. Kim SW, Oh YM, Choe SM, Choe GH, Park KN, Oh JS. Practical application of semiquantitative procalcitonin test in emergency department. J Korean Soc Emerg Med 2008;19:665-671.
16. Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003;29:579-583.
17. Level C, Chauveau P, Delmas Y, et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001;16:980-986.
18. Montagnana M, Lippi G, Tessitore N, et al. Procalcitonin values after dialysis is closely related to type of dialysis membrane. Scand J Clin Lab Invest 2009;69:703-707.
19. Herget-Rosenthal S, Klein T, Marggraf G, et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 2005;61:180-186.
20. Lee SJ, Jung YC, Jeon DO, et al. High serum C-reactive protein level predicts mortality in patients with stage 3 chronic kidney disease or higher and diabetic foot infections. Kidney Res Clin Pract 2013;32:171-176.